ABIVAX Société Anonyme (ABVX) Discusses Positive Phase III ABTECT Trial Results for Obefazimod in Ulcerative Colitis Transcript
Source: SeekingAlpha
2026-06-02 09:51:51 ET
ABIVAX Société Anonyme (ABVX) Discusses Positive Phase III ABTECT Trial Results for Obefazimod in Ulcerative Colitis June 1, 2026 4:30 PM EDT...
Read the full article on Seeking Alpha
For further details see:
ABIVAX Société Anonyme (ABVX) Discusses Positive Phase III ABTECT Trial Results for Obefazimod in Ulcerative Colitis Transcript
Abivax SA
NASDAQ: ABVX
ABVX Trading
16.69% G/L:
$96.675 Last:
2,535,573 Volume:
$93.30 Open:
ABVX Latest News
June 03, 2026 08:53:00 pm
ABVX Investors Have Opportunity to Join Abivax S.A. Fraud Investigation with the Schall Law Firm
June 02, 2026 09:20:00 pm
Abivax Investigation Initiated: SueWallSt Investigates the Officers and Directors of Abivax (ABVX)
ABVX Stock Data
$9,359,969,582
53,161,297
N/A
64
N/A
Biotechnology & Life Sciences
Healthcare
FR
Paris
